Incidence and Prediction of Symptoms and Drug Sensitivity Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) for Treatment of Latent Tuberculosis Infection
1 of 2
Factors that Influence the Prevalence of Latent Tuberculosis Infection among Healthcare Workers in Thailand